Puig 发布 Vision 2032:剑指 80 亿欧元,做前四大高端美妆
CEO José Manuel Albesa Eyes €8 Billion Sales Milestone for Puig
Puig 在首届资本市场日发布 Vision 2032:新 CEO Albesa 定下 2032 年前营收超 80 亿欧元、利润率超 22.5% 的目标,主攻高端香水、扩大小众香水在美布局,并把 Charlotte Tilbury 做到 1.5 倍、Uriage 翻倍。
In Madrid’s Museo del Prado on Wednesday, José Manuel Albesa put his first stake in the ground: a strategy to make Puig an €8 billion-plus company in the next six years.
Manuel Albesa became Puig CEO in March 2026, after Marc Puig stepped down following 22 years in the role (he remains executive chair of the Puig board). In 2021, Marc Puig set out a strategic plan, called Vision 2025, with the goal of tripling sales in five years. The company delivered. Puig revenues hit €5 billion in 2025, up 7.8% on a like-for-like basis.
Now, Manuel Albesa is hoping to further this success with Vision 2032, a roadmap he presented at the Spanish beauty and fashion conglomerate’s first-ever Capital Markets Day.
“Vision 2032 is our plan to scale what works, profitably,” Manuel Albesa said in a statement shared ahead of the presentations. “Our ambition is to become an €8 billion-plus company by 2032, a top four premium beauty company and a top two fragrance player, while reaching an adjusted EBITDA margin above 22.5%. We expect to deliver this ambition primarily through organic growth, driven by reinforcing our core portfolio, scaling our strongest brands and concentrating our resources on the categories, markets and channels where we have the clearest opportunity to win.”
Puig — which owns brands including Rabanne, Charlotte Tilbury, and Dries Van Noten — began trading publicly on May 3, 2024, as a listed company on the Barcelona, Madrid, Bilbao and Valencia Stock Exchanges.
.jpg&mode=full&exp=1793404800&sig=9a4ba6ac2b6e5250)
Charlotte Tilbury is one of the three brands in Puig’s portfolio with sales in the €1 billlion ballpark, alongside Rabanne and Carolina Herrera.
Photo: Courtesy of PuigLast week, Puig announced that revenues rose 5.6% in the third quarter on a like-for-like basis to €1.39 billion. Despite the strong performance, the company remains small compared to some of its rivals (by comparison, L’Oréal’s Q3 2026 sales were up 6.9% to €35.3 billion). Earlier this year, Puig began merger talks with Estée Lauder Companies, which ended in May following separate announcements that an agreement was not reached.
Still, it’s been a busy year for Puig, which announced on September 14 that it had acquired the remaining 50% of Spanish dermocosmetics brand ISDIN. (Puig initially owned half of the brand since partnering on its launch with the Esteve family in 1975.) This is part of a larger investment strategy. During his speech at Wednesday’s Capital Markets Day, Marc Puig announced a non-material minority investment in Kreme, an independent French dermocosmetics company focused on microbiome-based skincare products.
“Puig enters this next chapter from a position of strength. Today, we are stronger than at any point in our over 110-year history,” Marc Puig stated. “We have a distinctive culture and a long-term vision rooted in family ownership, professional management, and an identity that we define as a home of creativity. This has taken Puig beyond €5 billion in net revenues in 2025, more than tripling revenues in the last five years, and provides the foundation for Vision 2032.”
To reach €8 billion by 2032, Puig’s new set of objectives includes doubling down on prestige fragrance (Carolina Herrera, Jean Paul Gaultier, and Rabanne), expanding its niche fragrance portfolio (notably Byredo and Penhaligon’s in the US), multiplying the Charlotte Tilbury business by 1.5x by 2032 (sales are currently hovering at €1 billion), and doubling that of Uriage by 2032.
来源:颜如玉编辑台 · vogue.com
.jpg&mode=full&exp=1793404800&sig=5c91c083462c74ee)